AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(14 sites)

United States

University of California, San Diego, La Jolla, California

Georgetown University Hospital Pasquerilla Healthcare Center, Washington D.C., District of Columbia

University of Florida, Gainesville, Florida

Mayo Clinic in Florida, Jacksonville, Florida

Orlando Regional Medical Center, Orlando Health Neuroscience Institute, Orlando, Florida